Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Atropine Sulfate Injection
Status: Currently in Shortage
»Date first posted:
01/01/2012
»Therapeutic Categories: Anesthesia; Neurology; Pediatric
Accord Healthcare Inc. (Revised 04/16/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, .4 mg/1 mL (NDC 16729-525-08) | Unavailable | Shortage duration not available. | Requirements related to complying with good manufacturing practices |
| Injection, .4 mg/1 mL (NDC 16729-512-43) | Unavailable | Shortage duration not available. | Requirements related to complying with good manufacturing practices |
| Injection, 1 mg/1 mL (NDC 16729-526-08) | Available | Stock Available; Inventory shipping to orders | Requirements related to complying with good manufacturing practices |
| Injection, .05 mg/1 mL (NDC 16729-483-03) | Unavailable | Temporary discontinuation of this SKU | Requirements related to complying with good manufacturing practices |
| Injection, .1 mg/1 mL (NDC 16729-484-45) | Unavailable | Shortage duration not available. | Requirements related to complying with good manufacturing practices |
| Injection, .1 mg/1 mL (NDC 16729-484-90) | Unavailable | Temporary discontinuation of this SKU | Requirements related to complying with good manufacturing practices |
American Regent, Inc. (Reverified 04/16/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 1 mg/1 mL (NDC 0517-1001-25) | Available | old NDC 0517-1010-25 | |
| Injection, .4 mg/1 mL (NDC 0517-1004-25) | Available | old NDC 0517-0401-25 |
Amphastar Pharmaceuticals, Inc. (Reverified 04/02/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, .1 mg/1 mL (NDC 76329-3340-1) | Available |
Fresenius Kabi USA, LLC (Reverified 04/16/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, .4 mg/1 mL (NDC 63323-580-20) | Available | Check wholesalers for inventory |
Hikma Pharmaceuticals USA, Inc. (Reverified 04/16/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 0.4 mg/1 mL (NDC 0641-6251-10) | Available | Additional lots are scheduled for manufacturing. Product will be made available as it is released. |
Hospira, Inc., a Pfizer Company (Revised 03/28/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Atropine Sulfate, Injection, .1 mg/1 mL (NDC 0409-1630-10) | Unavailable | Next Delivery: April 2024; Estimated Recovery: June 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Atropine Sulfate, Injection, .05 mg/1 mL (NDC 0409-9630-05) | Available | ||
| Atropine Sulfate, Injection, .1 mg/1 mL (NDC 0409-4910-34) | Limited Availability | Limited Supply Available. Next Delivery: September 2024; Estimated Recovery: December 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Atropine Sulfate, Injection, .1 mg/1 mL (NDC 0409-4911-34) | Unavailable | Next Delivery: June 2024; Estimated Recovery: December 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Injection, 0.1 mg/mL, 10 mL (NDC 0409-4911-11) | Unavailable | Next Delivery: June 2024; Estimated Recovery: TBD; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
Medefil, Inc. (Reverified 04/15/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Atropine Sulfate, Injection, .1 mg/1 mL (NDC 64253-400-91) | Available |